|
HIV Proteomics Center for Host Viral Response Characterization |
United States |
HIV/AIDS |
|
|
|
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT): START |
Uganda; Morocco; South Africa; Mali; Nigeria; China; Japan; India; Malaysia; Thailand; Israel; Mexico; Brazil; Chile; Peru; Uruguay; Australia |
HIV/AIDS |
|
|
|
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) |
United States |
HIV/AIDS |
|
|
|
HIV Tropism, Persistence, Inflammation, and Neurocognition in Therapy Initiation |
United States |
HIV/AIDS, Dementia and Cognitive Impairment |
|
|
|
The Pathobiology of Primary HIV-1 Infection |
United States |
HIV/AIDS |
|
|
|
Defining CNS HIV Infection and Its Effects in Treated Patients: Foundation for Eradication |
United States |
HIV/AIDS |
|
|
|
Central Nervous System HIV Translational Research Training Program |
United States |
HIV/AIDS, Neurology and Mental Health, Residencies, Fellowships, and Postdoctoral Training |
|
|
|
The Neuropathobiology of Primary HIV-1 Infection |
United States |
HIV/AIDS, Neurology and Mental Health |
|
|
|
CNS Immune / Inflammatory Biomarkers in HIV Controllers |
United States |
HIV/AIDS, Immunology |
|
|
|
Compartmentalized CSF viral escape and the CNS HIV reservoir |
United States |
HIV/AIDS, Neurology and Mental Health |
|
|
|
Cross-Sectional Examination of Cerebrospinal Fluid Kinetic Biomarkers of Axonal Transport for Amyotrophic Lateral Sclerosis (Als) Diagnosis and Progression |
United States |
Drug and Diagnostics Development |
|
|